APYX EQUITY ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Apyx Medical Corporation Investors With Losses to Get Counsel Before Important Deadline in Securities Class Action – APYX |

NEW YORK, June 17, 2022 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of Apyx Medical Corporation (NASDAQ: APYX) securities between May 12, 2021 and March 11, 2022both dates included (the “Class Period”), of the material August 5, 2022 lead applicant deadline.

SO WHAT: If you purchased Apyx securities during the Class Period, you may be entitled to compensation without payment of fees or out-of-pocket costs through a contingent fee arrangement.

WHAT TO DO NEXT: To join the Apyx class action, go to https://rosenlegal.com/submit-form/?case_id=6835 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information. A class action lawsuit has already been filed. If you wish to act as lead plaintiff, you must move the Court not later than August 5, 2022. A lead plaintiff is a representative party acting on behalf of other class members to direct litigation.

WHY THE ROSEN LAW: We encourage investors to select qualified lawyers with proven track records in leadership roles. Often, companies issuing reviews do not have comparable experience, resources, or significant peer recognition. Many of these firms do not actually handle securities class action lawsuits, but are merely middlemen who refer clients or partner with law firms that actually litigate the cases. Be wise in choosing lawyers. Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder derivative litigation. Rosen Law Firm has reached the largest securities class action settlement against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has ranked in the top 4 every year since 2013 and has recovered hundreds of million dollars for investors. In 2019 alone, the company obtained more than $438 million for investors. In 2020, founding partner Laurence Rosen has been named by law360 as a Titan of the Plaintiffs Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, the defendants throughout the class period made false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx’s Advanced Energy products were used for off-label indications; (2) these off-label uses have resulted in an increase in the number of medical device reports filed by Apyx of serious adverse events; (3) as a result, Apyx was reasonably likely to be subject to regulatory review; (4) as a result of the foregoing, Apyx’s financial results would be adversely affected; and (5) as a result of the foregoing, defendants’ positive statements regarding Apyx’s business, operations and prospects were materially misleading and/or lacked reasonable basis. When the real details entered the market, the lawsuit claims investors suffered damages.

To join the Apyx class action, go to https://rosenlegal.com/submit-form/?case_id=6835 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information.

No class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the lawyer of your choice. You can also remain an absent party member and do nothing at this point. An investor’s ability to participate in any potential future recovery does not depend on their status as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Lawyer advertisement. Previous results do not guarantee a similar result.

Contact information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, Pennsylvania

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

See original content to download multimedia: https://www.prnewswire.com/news-releases/apyx-equity-alert-rosen-trusted-national-trial-counsel-encourages-apyx-medical-corporation-investors-with -losses-to-secure-the-lawyer-before-a-significant-delay-in-the-collective-action-in-titles–apyx-301570519.html

SOURCE Rosen Law Firm, Pennsylvania

Luisa D. Fuller